Compound information
- Natural Products
- ZC1309886
- Molecular Formula
- C26H32N8O3
- Molecular Weight
- 504.259736884 g/mol
- Structure
-
- IUPAC Name
- 4-amino-N-[4-[2-(dimethylamino)-2-oxo-ethyl]-2,3-dimethyl-phenyl]-1-[(3R)-1-prop-2-enoyl-3-piperidyl]pyrazolo[3,4-d]pyrimidine-3-carboxamide
- InChI
- InChI=1S/C26H32N8O3/c1-6-20(35)33-11-7-8-18(13-33)34-25-22(24(27)28-14-29-25)23(31-34)26(37)30-19-10-9-17(15(2)16(19)3)12-21(36)32(4)5/h6,9-10,14,18H,1,7-8,11-13H2,2-5H3,(H,30,37)(H2,27,28,29)/t18-/m1/s1
- InChI Key
- JCCIICHPRAAMGK-GOSISDBHSA-N
- SMILES
- C=CC(=O)N1CCC[C@@H](n2nc(C(=O)Nc3ccc(CC(=O)N(C)C)c(C)c3C)c3c(N)ncnc32)C1
- Source
- ZINC001772572783
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 4 |
Heteroatom Count | 11 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 139.34 Å2 | LogP | 1.687 |
LogS | -2.945 | LogD | 2.234 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.991 | Pgp substrate | 0.999 |
HIA | 0.964 | F20 % | 0.916 |
F30 % | 0.618 | Caco-2 | -5.485 |
MDCK | -5.248 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.548 | PPB | 88.814 |
VD | 0.672 | Fu | 0.637 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.007 | CYP1A2 substrate | 0.58 |
CYP2A6 substrate | 0.216 | CYP2B6 substrate | 0.249 |
CYP2C19 inhibitor | 0.123 | CYP2C19 substrate | 0.509 |
CYP2C8 substrate | 0.434 | CYP2C9 inhibitor | 0.143 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.05 |
CYP2D6 substrate | 0.829 | CYP2E1 substrate | 0.259 |
CYP3A4 inhibitor | 0.225 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.403 | CL | 5.34 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.029 | Hepatotoxicity | 0.894 |
Mutagenicity | 0.472 | Rat Oral Acute Toxicity | 0.086 |
FDAMDD | 0.98 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.988 | Eye Corrosion | 0.004 |
Eye Irritation | 0.006 | Respiratory Toxicity | 0.577 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.302 | IGC50 | 3.695 |
LC50FM | -14.648 | LC50DM | 1.034 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.161 | NR-AR-LBD | 0.795 |
NR-AhR | 0.602 | NR-Aromatase | 0.026 |
NR-ER | 0.556 | NR-ER-LBD | 0.331 |
NR-PPAR-gamma | 0.828 | SR-ARE | 0.749 |
SR-ATAD5 | 0.787 | SR-HSE | 0.094 |
SR-MMP | 0.012 | SR-p53 | 0.757 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.